The PennZone

BELLEFONTE, Pa. - PennZone -- Actuated Medical, Inc. is pleased to announce that Roger B. Bagwell, Ph.D. is now the Actuated Medical Director, Neural Device Operations. This transition reflects the company's continued expansion in the neural device sector and Dr. Bagwell's pivotal role in advancing Actuated's cutting-edge technologies.

As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.

"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.

More on The PennZone

• Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
• IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
• Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
• BPM Systems Launches New Automated Packaging & Labeling Solution for Manufacturers Across The US
• EnergyStrat Launches Global LNG Risk Outlook 2025–2030

"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.

Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.

About Actuated Medical, Inc.

Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com

More on The PennZone

• Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
• Holiday Decorations Most Likely to Cause Injuries
• UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
• Zac Arbitman Elected As Co-Chair of Philadelphia Bar Association Federal Courts Committee
• CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

ActuatedMedical.com

GripTract.com

ActuatedNeuroscience.com

TubeClear.com